4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-025664
Chief Medical Officer sold 15,000 shares at an average $37.77 ($566,536)
- Chief Medical Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crystal Adam Chief Medical Officer | 2021-04-05 | Option exercise | +15,000 | $6.50 | $97,500 | 15,000 | D |
| Crystal Adam Chief Medical Officer | 2021-04-05 | Sale | −4,121 | $37.16 | $153,129 | 10,879 | D |
| Crystal Adam Chief Medical Officer | 2021-04-05 | Sale | −10,879 | $38.00 | $413,407 | 0 | D |
| Derivatives | |||||||
| Crystal Adam Chief Medical Officer | 2021-04-05 | Option exercise · Common Stock | −15,000 | 157,292 | D | ||
| Open-market sales · 15,000 sh · avg $37.77 · $566,536 | |||||||
Loading xslF345X03/doc4.xml…